These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Xenotransplantation of canine, bovine, and porcine islets in diabetic rats without immunosuppression. Lanza RP; Butler DH; Borland KM; Staruk JE; Faustman DL; Solomon BA; Muller TE; Rupp RG; Maki T; Monaco AP Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11100-4. PubMed ID: 1763025 [TBL] [Abstract][Full Text] [Related]
11. Use of xenogeneic islets in hybrid artificial pancreas for treatment of diabetes without immunosuppression. Ohzato H; Carretta M; Maki T; Sullivan SJ; Borland K; Muller TE; Solomon BA; Chick WL; Monaco AP Transplant Proc; 1992 Apr; 24(2):661-2. PubMed ID: 1566471 [No Abstract] [Full Text] [Related]
12. The effect of transplantation site and islet mass on long-term survival and metabolic and hormonal function of canine purified islet autografts. Scharp DW; Marchetti P; Swanson C; Newton M; McCullough CS; Olack B Cell Transplant; 1992; 1(2-3):245-54. PubMed ID: 1344296 [TBL] [Abstract][Full Text] [Related]
13. Characterization and transplantation of agarose microencapsulated canine islets of Langerhans. Tashiro H; Iwata H; Warnock GL; Takagi T; Machida H; Ikada Y; Tsuji T Ann Transplant; 1997; 2(3):33-9. PubMed ID: 9869862 [TBL] [Abstract][Full Text] [Related]
15. Ex vivo evaluation in normal dogs of insulin released by a bioartificial pancreas containing isolated rat islets of Langerhans. Lepeintre J; Briandet H; Moussy F; Chicheportiche D; Darquy S; Rouchette J; Imbaud P; Duron JJ; Reach G Artif Organs; 1990 Feb; 14(1):20-7. PubMed ID: 2105710 [TBL] [Abstract][Full Text] [Related]
16. Treatment of severe diabetes mellitus for more than one year using a vascularized hybrid artificial pancreas. Maki T; Lodge JP; Carretta M; Ohzato H; Borland KM; Sullivan SJ; Staruk J; Muller TE; Solomon BA; Chick WL Transplantation; 1993 Apr; 55(4):713-7; discussion 717-8. PubMed ID: 8475540 [TBL] [Abstract][Full Text] [Related]
17. Influence of VEGF on the viability of encapsulated pancreatic rat islets after transplantation in diabetic mice. Sigrist S; Mechine-Neuville A; Mandes K; Calenda V; Braun S; Legeay G; Bellocq JP; Pinget M; Kessler L Cell Transplant; 2003; 12(6):627-35. PubMed ID: 14579931 [TBL] [Abstract][Full Text] [Related]
18. Treatment of diabetes by xenogeneic islets without immunosuppression. Use of a vascularized bioartificial pancreas. Maki T; Otsu I; O'Neil JJ; Dunleavy K; Mullon CJ; Solomon BA; Monaco AP Diabetes; 1996 Mar; 45(3):342-7. PubMed ID: 8593940 [TBL] [Abstract][Full Text] [Related]
19. Kinetic modelling as a tool for the design of a vascular bioartificial pancreas: feedback between modelling and experimental validation. Reach G; Jaffrin MY Comput Methods Programs Biomed; 1990; 32(3-4):277-85. PubMed ID: 2249427 [TBL] [Abstract][Full Text] [Related]
20. Successful allotransplantation of encapsulated islets in pancreatectomized canines for diabetic management without the use of immunosuppression. Wang T; Adcock J; Kühtreiber W; Qiang D; Salleng KJ; Trenary I; Williams P Transplantation; 2008 Feb; 85(3):331-7. PubMed ID: 18301328 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]